CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
102 hedge funds and large institutions have $42.9M invested in Clovis Oncology, Inc. in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less capital invested
Capital invested by funds: $75.6M → $42.9M (-$32.7M)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
Holders
102
Holding in Top 10
1
Calls
$4.99M
Puts
$2.38M
Top Buyers
| 1 | +$2.22M | |
| 2 | +$832K | |
| 3 | +$779K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$622K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$349K |
Top Sellers
| 1 | -$6.9M | |
| 2 | -$1.58M | |
| 3 | -$1.27M | |
| 4 |
BlackRock
New York
|
-$1.07M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.02M |